Chemours Income Statement
CC / Materials|13 years of annual SEC 10-K data (FY2013-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 13 fiscal years. All figures from audited SEC 10-K filings.
Chemours reported $5.8B in revenue and $339M in net loss for FY2025. Revenue has declined at a 1.4% compound annual rate over the past 12 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
- High leverage: Debt-to-equity ratio of 7.19
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.8B | $5.8B | $6.1B | $6.8B | $6.3B | $5.0B | $5.5B | $6.6B | $6.2B | $5.4B | $5.7B | $6.4B | $6.9B |
| Cost of Revenue | $4.9B | $4.6B | $4.8B | $5.2B | $5.0B | $3.9B | $4.5B | $4.7B | $4.4B | $4.3B | $4.8B | $5.1B | $5.4B |
| Gross Profit | $902.0M | $1.1B | $1.3B | $1.6B | $1.4B | $1.1B | $1.1B | $2.0B | $1.7B | $1.1B | $955.0M | $1.4B | $1.5B |
| SG&A Expense | $547.0M | $598.0M | $1.3B | $710.0M | $592.0M | $527.0M | $548.0M | $657.0M | $626.0M | $946.0M | $632.0M | $685.0M | $768.0M |
| R&D Expense | $108.0M | $109.0M | $108.0M | $118.0M | $107.0M | $93.0M | $80.0M | $82.0M | $81.0M | $81.0M | $97.0M | $143.0M | $164.0M |
| Interest Expense | $269.0M | $263.0M | $208.0M | $163.0M | $185.0M | $210.0M | $208.0M | $195.0M | $214.0M | $219.0M | $132.0M | $0 | $0 |
| Income Tax | $135.0M | $37.0M | -$66.0M | $163.0M | $68.0M | -$40.0M | -$72.0M | $159.0M | $165.0M | -$18.0M | -$98.0M | $149.0M | $152.0M |
| Net Income | -$339.0M | $69.0M | -$253.0M | $578.0M | $608.0M | $219.0M | -$52.0M | $995.0M | $746.0M | $7.0M | -$90.0M | $400.0M | $423.0M |
| EPS (Basic) | -$1.70 | $3.72 | $3.69 | $1.33 | -$0.32 | $5.62 | $4.04 | $0.04 | -$0.50 | $2.21 | $2.34 | $2.21 | $2.34 |
| EPS (Diluted) | -$1.70 | $3.65 | $3.60 | $1.32 | -$0.32 | $5.45 | $3.91 | $0.04 | -$0.50 | $2.21 | $2.34 | $2.21 | $2.34 |
| Shares Outstanding | 149.4M | 148.6M | 148.5M | 161.0M | 164.9M | 163.6M | 170.8M | 183.0M | 182.6M | 181.1M | 181.1M | 181.0M | 181.0M |
| Gross Margin | 15.5% | 19.8% | 21.4% | 23.7% | 21.8% | 21.5% | 19.2% | 29.7% | 28.2% | 20.4% | 16.7% | 21.1% | 21.3% |
| Profit Margin | -5.8% | 1.2% | -4.2% | 8.5% | 9.6% | 4.4% | -0.9% | 15.0% | 12.1% | 0.1% | -1.6% | 6.2% | 6.2% |